Your browser doesn't support javascript.
loading
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population.
Bonadonna, R C; Giaccari, A; Buzzetti, R; Aimaretti, G; Cucinotta, D; Avogaro, A; Perseghin, G; Larosa, M; Bolli, G B; Fanelli, C G.
Afiliación
  • Bonadonna RC; Division of Endocrinology and Metabolic Diseases, Department of Medicine and Surgery, University of Parma, AOU of Parma, Italy. Electronic address: riccardo.bonadonna@unipr.it.
  • Giaccari A; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome and Università Cattolica del Sacro Cuore, Rome, Italy.
  • Buzzetti R; Sapienza University of Rome, Italy.
  • Aimaretti G; University of the Eastern Piedmont, Italy.
  • Cucinotta D; University of Messina, Italy.
  • Avogaro A; University of Padua, Italy.
  • Perseghin G; University of Milan Bicocca, Italy.
  • Larosa M; Sanofi, Milan, Italy.
  • Bolli GB; Section of Endocrinology and Metabolism, Department of Medicine, Perugia University Medical School, Italy.
  • Fanelli CG; Section of Endocrinology and Metabolism, Department of Medicine, Perugia University Medical School, Italy.
Nutr Metab Cardiovasc Dis ; 29(5): 496-503, 2019 05.
Article en En | MEDLINE | ID: mdl-30952575
BACKGROUND AND AIMS: Fostering patient's self-managing of basal insulin therapy could improve glucose control, by removing patient's and physician's barriers to basal insulin initiation, titration and glucose monitoring. The Italian Titration Approaches Study (ITAS) aims at demonstrating non-inferiority (<0.3% margin) in efficacy of glucose control (change in glycated hemoglobin [HbA1c] after 24 weeks) by the same titration algorithm of insulin glargine 300 U/mL (Gla-300), managed by the (nurse assisted) patient versus the physician, in insulin naïve patients with Type 2 Diabetes Mellitus (T2DM), uncontrolled with previous treatments. METHODS AND RESULTS: ITAS is a phase IV, 24-week, national, multicenter, open label, randomized (1:1) parallel group study. 458 patients were enrolled, 359 randomized, and 339 completed the study, in 46 Italian centers. Baseline characteristics and previous medications of the ITT population (N = 355) are reported. Mean ± SD age, T2DM duration, HbA1c, FPG and BMI were 64.0 ± 9.8 years, 11.6 ± 7.6 years, 8.79 ± 0.65%, 170.9 ± 42.3 mg/dL, and 30.3 ± 5.6 kg/m2, respectively. Vascular and metabolic disorders were most frequent (73.8% and 58.3%, respectively). More than 90% of patients were on metformin. CONCLUSION: ITAS is the first study to compare two different managers (nurse-assisted patient vs physician) of the same titration algorithm of Gla-300 in insulin naïve patients with T2DM in unsatisfactory glucose control. This study might provide novel evidence on the efficacy/effectiveness of patient-managed titration algorithm of Gla-300 in a pragmatic setting and may reduce barriers to basal insulin initiation and its titration.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autocuidado / Glucemia / Diabetes Mellitus Tipo 2 / Insulina Glargina / Hipoglucemiantes Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Nutr Metab Cardiovasc Dis Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / CIENCIAS DA NUTRICAO / METABOLISMO Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autocuidado / Glucemia / Diabetes Mellitus Tipo 2 / Insulina Glargina / Hipoglucemiantes Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Nutr Metab Cardiovasc Dis Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / CIENCIAS DA NUTRICAO / METABOLISMO Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos